<?xml version="1.0" encoding="UTF-8"?>
<ref id="B107-biomedicines-08-00109">
 <label>107.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tian</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Potent binding of novel 2019 coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody</article-title>
  <source>Emerg. Mircobes. Infect.</source>
  <year>2020</year>
  <volume>9</volume>
  <fpage>382</fpage>
  <lpage>385</lpage>
  <pub-id pub-id-type="doi">10.1080/22221751.2020.1729069</pub-id>
  <?supplied-pmid 32065055?>
  <pub-id pub-id-type="pmid">32065055</pub-id>
 </element-citation>
</ref>
